Insights from the Society of Infectious Diseases Pharmacists on antimicrobial stewardship guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America (Q37461442)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 2009

Language	Label	Description	Also known as
English	Insights from the Society of Infectious Diseases Pharmacists on antimicrobial stewardship guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America	scientific article published on May 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Insights from the Society of Infectious Diseases Pharmacists on antimicrobial stewardship guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

1 reference

based on heuristic

inferred from title

Society of Infectious Diseases Pharmacists

6

object named as

Society of Infectious Diseases Pharmacists

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

author name string

Richard H Drew

1

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Roger White

2

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Conan MacDougall

3

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Elizabeth D Hermsen

4

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Robert C Owens

5

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

language of work or name

0 references

publication date

1 May 2009

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

593-607

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

The impact of antimicrobial resistance on health and economic outcomes

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001).

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Clostridium difficile-associated disease: an emerging threat to patient safety: insights from the Society of Infectious Diseases Pharmacists

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Does antibiotic selection impact patient outcome?

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Do resident physicians use antibiotics appropriately in treating upper respiratory infections? A survey of 11 programs

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Tensions in antibiotic prescribing: pitting social concerns against the interests of individual patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Antibiotic optimization. An evaluation of patient safety and economic outcomes

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Cost-effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Concurrent antibiotic review programs--a role for infectious diseases specialists at small community hospitals

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Role of infectious diseases consultants in management of antimicrobial use in hospitals

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Impact of a hospital-based antimicrobial management program on clinical and economic outcomes

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Antimicrobial stewardship programs in health care systems

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Antimicrobial stewardship programs as a means to optimize antimicrobial use. Insights from the Society of Infectious Diseases Pharmacists

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Controlled trials to improve antibiotic utilization: a systematic review of experience, 1984-2004.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

A pseudo-outbreak of nosocomial infections associated with the introduction of an antibiotic management programme

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Demand for prophylaxis after bioterrorism-related anthrax cases, 2001

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

A qualitative study of factors influencing antimicrobial prescribing by non-consultant hospital doctors.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Information technology for optimizing the management of infectious diseases

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Maximizing appropriate antibiotic prophylaxis for surgical patients: an update from LDS Hospital, Salt Lake City

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Evaluation of a computer-assisted antibiotic-dose monitor

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care unit ward

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant Gram-negative bacteria among intensive care unit patients.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Effects of an antibiotic cycling program on antibiotic prescribing practices in an intensive care unit

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Adjustment of antibiotic treatment according to the results of blood cultures leads to decreased antibiotic use and costs

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Institute

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Epidemiological interpretation of antibiotic resistance studies - what are we missing?

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Room for improvement: a systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.593

21 January 2018

Identifiers

10.1592/PHCO.29.5.593

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37461442&oldid=1706573983"